Advertisement
Home Tags Immunotherapy

Tag: Immunotherapy

ASCO: Ivonescimab Improves Progression-Free Survival in EGFR+ Lung Cancer

0

PFS benefit seen in most subgroups, including those whose disease progressed while receiving third-generation EGFR-TKIs

Neoadjuvant Nivolumab, Ipilimumab Safe for dMMR Colon Cancer

0

113 of 115 enrolled patients underwent timely surgery; two had surgery delayed by more than two weeks

Recommendations Developed to Prepare Patients for Oral Immunotherapy

0

76 statements specific to OIT preparatory procedures were included, as well as 71 on the consent information form

Guideline Issued for Management of Inhalant Allergies With Immunotherapy

0

Authors strongly recommend that clinician performing allergy skin testing or allergen immunotherapy be able to diagnose, manage anaphylaxis

Pembrolizumab Improves Event-Free Survival in Early NSCLC

0

For resectable early-stage NSCLC, improved event-free survival seen with pembrolizumab, regardless of N status, clinical stage, type of surgery

Secondary Primary Malignancies Rare After CAR T-Cell Immunotherapy

0

Projected five-year incidence of 15.2 and 2.3 percent for solid and hematologic malignancies after CAR T-cell immunotherapy

Cancer Vaccine Safe, Induces T-Cell Responses for KRAS-Mutated Tumors

0

Lymph node-targeting Amphiphile vaccine is safe; correlation seen for efficacy with T-cell response

End-of-Life Treatment With Immunotherapy Increasing for Patients With Cancer

0

Those treated at nonacademic or low-volume facilities have higher odds of initiating therapy within one month of death

MSI-H Colorectal Cancer Rarely Recurs After Immunotherapy Cessation

0

88 percent of 64 patients remained without disease progression after median of 22.6 months after stopping immunotherapy

ASH: Ibrutinib-Venetoclax Beneficial for Relapsed/Refractory Lymphoma

0

Improvement seen in progression-free survival for patients with relapsed/refractory mantle cell lymphoma